{{scheme.chgp}}%
{{scheme.chgp}}%
No Matches Found
{{scheme.chgp}}%
No Matches Found
No Matches Found
Biomea Fusion, Inc.
Is Biomea Fusion, Inc. technically bullish or bearish?
As of June 3, 2025, Biomea Fusion, Inc. exhibits a mildly bearish trend due to daily moving averages and weekly RSI indicating bearish momentum, despite some mildly bullish signals from the weekly MACD.
What does Biomea Fusion, Inc. do?
Biomea Fusion, Inc. is a micro-cap company in the Pharmaceuticals & Biotechnology industry, currently reporting a net profit loss of $29 million and a market cap of $108.96 million. Key financial metrics include a P/E ratio of NA, a dividend yield of 0.00%, and a return on equity of -447.60%.
How big is Biomea Fusion, Inc.?
As of Jun 18, Biomea Fusion, Inc. has a market capitalization of 108.96 million and reported net sales of 0.00 million with a net profit of -128.63 million for the latest four quarters. The company has shareholder's funds of 51.57 million and total assets of 79.94 million as of Dec 24.
{{list.post_title}}
{{list.post_excerpt}}
{{list.post_title}}
{{list.post_excerpt}}
